Decheng Capital Management III (Cayman)’s Immunogen Inc IMGN Stock Holding History

Decheng Capital Management III (Cayman)’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$6.6M	Buy	+415,880	New	+$6.92M	2.2%	14

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Management III (Cayman)'s IMGN Position: Q3 2023 in Review

Decheng Capital Management III (Cayman) opened a new position in Immunogen Inc (IMGN) in Q3 2023: 415,880 shares worth $6.6M. The stake represents 2.2% of the portfolio and ranks #14 among its holdings.

275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

Decheng Capital Management III (Cayman) held 415,880 shares of Immunogen Inc worth $6.6M as of Q3 2023.
Immunogen Inc was a new Decheng Capital Management III (Cayman) position in Q3 2023.
Immunogen Inc made up 2.2% of Decheng Capital Management III (Cayman)'s portfolio in Q3 2023, its #14 holding.
275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on Decheng Capital Management III (Cayman)'s 13F filing for Q3 2023, filed 13 Nov 2023.